All Stories

  1. 3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition

    Article • Neuroscience, May 2018, Elsevier

    Dr Mauro Federici

  2. Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease

    Article • Nature Communications, April 2017, Nature

    Dr Mauro Federici

  3. Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats

    Article • Experimental Neurology, January 2017, Elsevier

    Dr Mauro Federici

  4. Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis

    Article • Neurobiology of Disease, February 2015, Elsevier

    Dr Mauro Federici, PhD Georgia Mandolesi

  5. Dysfunctional dopaminergic neurotransmission in asocial BTBR mice

    Article • Translational Psychiatry, August 2014, Nature

    Dr Mauro Federici

  6. Paradoxical Abatement of Striatal Dopaminergic Transmission by Cocaine and Methylphenidate

    Article • Journal of Biological Chemistry, November 2013, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Mauro Federici

  7. Electrophysiological and amperometric evidence that modafinil blocks the dopamine uptake transporter to induce behavioral activation

    Article • Neuroscience, November 2013, Elsevier

    Dr Andrea Romigi, Dr Mauro Federici

  8. PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity

    Article • Movement Disorders, October 2013, Wiley

    Dr Mauro Federici, Paola Bonsi

  9. Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter

    Article • European Journal of Neuroscience, October 2011, Wiley

    Dr Mauro Federici

  10. Role of Aberrant Striatal Dopamine D1 Receptor/cAMP/Protein Kinase A/DARPP32 Signaling in the Paradoxical Calming Effect of Amphetamine

    Article • Journal of Neuroscience, August 2010, Society for Neuroscience

    Dr Mauro Federici

  11. Trace amines depress D2-autoreceptor-mediated responses on midbrain dopaminergic cells

    Article • British Journal of Pharmacology, April 2010, Wiley

    Dr Mauro Federici

  12. Ethanol enhances GABAB-mediated inhibitory postsynaptic transmission on rat midbrain dopaminergic neurons by facilitating GIRK currents

    Article • European Journal of Neuroscience, April 2009, Wiley

    Dr Mauro Federici

  13. The anorexic agents, sibutramine and fenfluramine, depress GABAB-induced inhibitory postsynaptic potentials in rat mesencephalic dopaminergic cells

    Article • British Journal of Pharmacology, February 2009, Wiley

    Dr Mauro Federici

  14. Chapter 25 Oxidative Stress in Stroke Pathophysiology

    Article • January 2009, Elsevier

    Professor Diana Amantea, Dr Mauro Federici, Prof Giacinto Bagetta

  15. Differential effect of carbamazepine and oxcarbazepine on excitatory synaptic transmission in rat hippocampus

    Article • Synapse, October 2008, Wiley

    Dr Mauro Federici

  16. Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility

    Article • Molecular and Cellular Neuroscience, February 2008, Elsevier

    Dr Mauro Federici

  17. Electrophysiologic Changes in Ventral Midbrain Dopaminergic Neurons Resulting from (+/−) -3,4-Methylenedioxymethamphetamine (MDMA—“Ecstasy”)

    Article • Biological Psychiatry, September 2007, Elsevier

    Dr Mauro Federici

  18. On the Effects of Psychostimulants, Antidepressants, and the Antiparkinsonian Drug Levodopa on Dopamine Neurons

    Article • Annals of the New York Academy of Sciences, August 2006, Wiley

    Dr Mauro Federici

  19. Dopamine-containing Neurons are Silenced by Energy Deprivation: A Defensive Response or Beginning of Cell Death?

    Article • NeuroToxicology, October 2005, Elsevier

    Dr Mauro Federici

  20. Actions of methylphenidate on dopaminergic neurons of the ventral midbrain

    Article • Biological Psychiatry, February 2005, Elsevier

    Dr Mauro Federici

  21. Trace Amines Depress GABAB Response in Dopaminergic Neurons by Inhibiting G-βγ-Gated Inwardly Rectifying Potassium Channels

    Article • Molecular Pharmacology, January 2005, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Mauro Federici

  22. Blockade of Nociceptin/Orphanin FQ Receptor Signaling in Rat Substantia Nigra Pars Reticulata Stimulates Nigrostriatal Dopaminergic Transmission and Motor Behavior

    Article • Journal of Neuroscience, July 2004, Society for Neuroscience

    Dr Mauro Federici

  23. Inhibitory effects of trace amines on rat midbrain dopaminergic neurons

    Article • Neuropharmacology, May 2004, Elsevier

    Dr Mauro Federici

  24. Dopamine selectively reduces GABA B transmission onto dopaminergic neurones by an unconventional presynaptic action

    Article • The Journal of Physiology, April 2002, Wiley

    Dr Mauro Federici

  25. Tranylcypromine, but not moclobemide, prolongs the inhibitory action of dopamine on midbrain dopaminergic neurons: An in vitro electrophysiological study

    Article • Synapse, January 2000, Wiley

    Dr Mauro Federici

  26. Inhibition of cathecol-O-methyltransferase (COMT) in the brain does not affect the action of dopamine and levodopa: an in vitro electrophysiological evidence from rat mesencephalic dopamine neurons

    Article • Journal of Neural Transmission, February 1999, Springer Science + Business Media

    Dr Mauro Federici

  27. Modification of levodopa responses by deprenyl (selegiline): An electrophysiological and behavioral study in the rat relevant to Parkinson's disease

    Article • Annals of Neurology, May 1998, Wiley

    Dr Mauro Federici

  28. Whole Cell Patch-Clamp Recordings of Rat Midbrain Dopaminergic Neurons Isolate a Sulphonylurea- and ATP-Sensitive Component of Potassium Currents Activated by Hypoxia

    Article • Journal of Neurophysiology, March 1998, American Physiological Society

    Dr Mauro Federici